| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/02/2002 | US20020052373 D4 dopamine receptor in combination with an acetylcholine esterase inhibitor. |
| 05/02/2002 | US20020052372 Using neurotrophic pipecolic acid derivative compounds having an affinity for FKBP-type immunophilins as inhibitors of the enzyme activity associated with immunophilin proteins |
| 05/02/2002 | US20020052371 Neuropeptide Y receptor antagonist; treatment of bulimia, obesity or diabetes; e.g., spiro(isobenzofuran-1-(3H),4'-pyridine)-1'-carboxamides |
| 05/02/2002 | US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder |
| 05/02/2002 | US20020052369 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 05/02/2002 | US20020052367 Pharmaceutical compositions containing carvedilol and hydrochlorothiazide |
| 05/02/2002 | US20020052366 Administering taurolidine, taurultam, or a biologically active derivative; induces tumor cell death by apoptosis. |
| 05/02/2002 | US20020052365 Selective anxiolytic therapeutic agents |
| 05/02/2002 | US20020052364 Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors |
| 05/02/2002 | US20020052363 Piperazine- or diazepine-containing compounds; useful in the treatment of cancer. |
| 05/02/2002 | US20020052361 Pharmaceutical compositions and method for the treatment of hypertension |
| 05/02/2002 | US20020052359 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/02/2002 | US20020052358 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 05/02/2002 | US20020052357 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 05/02/2002 | US20020052356 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 05/02/2002 | US20020052355 Inhibition of serotonin reuptake; especially 2-(azabicycloalkyl)alkylenyl)isoquinolin-3-one compounds |
| 05/02/2002 | US20020052354 Paramagnetic DOTA derivatives, pharmaceutical agents that contain the latter, process for their production, and their use for MR imaging of necrosis and infarction |
| 05/02/2002 | US20020052353 Methods of prevention and treatment of ischemic damage |
| 05/02/2002 | US20020052352 Treating a malignant tumor, like a melanoma, using plant-derived compounds |
| 05/02/2002 | US20020052351 Novel medical use for tachykinin antagonists |
| 05/02/2002 | US20020052350 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses |
| 05/02/2002 | US20020052349 p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 05/02/2002 | US20020052348 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 05/02/2002 | US20020052347 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates |
| 05/02/2002 | US20020052346 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) |
| 05/02/2002 | US20020052345 Novel prodrugs for phosphorus-containing compounds |
| 05/02/2002 | US20020052344 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase IB (PTP-IB) |
| 05/02/2002 | US20020052342 Lipophilic cation covalently coupled to an antioxidant moiety, especially compounds, containing a triphenyl phosphonium cation |
| 05/02/2002 | US20020052341 Bupropion metabolites and methods of their synthesis and use |
| 05/02/2002 | US20020052340 Treating disorders ameliorated by inhibition of neuronal monoamine reuptake, such as erectile dysfunction, affective disorders, cerebral function disorders, cigarette smoking, and incontinence. |
| 05/02/2002 | US20020052339 Methods for treatment of impulse control disorders |
| 05/02/2002 | US20020052338 Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof |
| 05/02/2002 | US20020052337 Composition and method for inhibiting platelet aggregation |
| 05/02/2002 | US20020052336 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 05/02/2002 | US20020052333 Therapeutic use of cis-element decoys in vivo |
| 05/02/2002 | US20020052332 Methods of inhibiting retinal pigment epithelial cell degeneration, stable cell lines, and uses |
| 05/02/2002 | US20020052328 Useful as antibacterial and antiprotozoal agents in mammals, including man, as well as in fish and birds. |
| 05/02/2002 | US20020052327 Novel sulfoquinovosylacylglycerol derivative, and use thereof as medicaments |
| 05/02/2002 | US20020052326 Treating diabetes and related diseases in combination with one, two or more other antidiabetic agents and/or one, two or more hypolipidemic agents. |
| 05/02/2002 | US20020052325 E.g., topiramate |
| 05/02/2002 | US20020052324 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor |
| 05/02/2002 | US20020052322 Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 05/02/2002 | US20020052319 Topical anesthetic/opioid formulations and uses thereof |
| 05/02/2002 | US20020052317 Anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 05/02/2002 | US20020052312 Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists |
| 05/02/2002 | US20020052310 Bioactive agent in association with a charged lipid wherein the charged lipid has an overall net charge which is opposite to the overall net charge of the agent upon association and wherein release of the agent is sustained. |
| 05/02/2002 | US20020052309 Use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium |
| 05/02/2002 | US20020052038 Polypeptide for use in the treatment of viral diseases and cancer |
| 05/02/2002 | US20020052035 18891, a novel human lipase |
| 05/02/2002 | US20020052033 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 05/02/2002 | US20020052028 Bio-intermediates for use in the chemical synthesis of polyketides |
| 05/02/2002 | US20020052013 Tumour-specific P450 protein |
| 05/02/2002 | US20020052007 Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives |
| 05/02/2002 | US20020051988 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 05/02/2002 | US20020051964 Intensifying semen activity; obtain semen sample, incubate with preferential oxidation resistant compounds, artifically impregnate animal, monitor animal for semen activity |
| 05/02/2002 | US20020051828 Mixtures which can be isolated from eugenia jambolana lamarck seeds, their preparation and the use of these mixtures and some of their constituents as medicaments |
| 05/02/2002 | US20020051825 A crude extract obtained by extracting Lagerstroemia speciosa belonging to the genus Lagerstroemia( banana plant) with water, hot water, an organic solvent or a mixed solution, used as xanthine oxidase inhibitor |
| 05/02/2002 | US20020051822 Enhancing bone formation, inhibiting osteoclastic differentiation or activating osteoblastic differentialation by administering to a human or animal suffering from, or susceptible to bone disease a lanthanum compound |
| 05/02/2002 | US20020051820 Polymeric matrix swells upon imbibition of water thereby attaining a size large enough to promote retention in stomach during feeding mode, that releases drug into gastric fluid by dissolution and diffusion of the drug out of matrix |
| 05/02/2002 | US20020051818 A core in the form of a tablet and having an enteric coating surrounding core, comprising an acid labile medicament, a binder or filler, a disintegrant and a lubricant, coating is formed of methacrylic acid copolymer and plasticizer |
| 05/02/2002 | US20020051817 Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof |
| 05/02/2002 | US20020051816 Beta-lactam antibiotic-containing tablet and production thereof |
| 05/02/2002 | US20020051815 Administering to a apnea disorder patient a therapeutically effective amount of R(+) ondansetron, or its hydrochloric salt, substantially free of its S(-) stereoisomer |
| 05/02/2002 | US20020051814 Composition for the treatment and prevention of ischemic events |
| 05/02/2002 | US20020051810 (a) ferulic acid or ester, and (b) caffeic acid and/or a chlorogenic acid |
| 05/02/2002 | US20020051807 Controlled release alprazolam in the core optionally in combination with an anti-psychotic agent, in a rapid release external coat; smaller, easier to swallow |
| 05/02/2002 | US20020051805 Colonic motor dysfunction remedies comprising aminothiazole derivatives as active ingredients |
| 05/02/2002 | US20020051800 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |
| 05/02/2002 | US20020051799 Glucosylated hydroxystilbene compounds for treating skin conditions |
| 05/02/2002 | US20020051795 Use treating diseases caused by pathologically elevated formation of free radicals; product packages; thrombolytic treatment, bypass surgery or percutaneous transluminal angioplasty |
| 05/02/2002 | US20020051793 Lipoteichoic acid immunogenic compositions and methods of making and using thereof |
| 05/02/2002 | US20020051787 Steroids, viricides, and anti-microbial neutralizing antibodies suspended in a carrier |
| 05/02/2002 | US20020051766 Treating an aliquot of patient's blood ex vivo with a stressor selected from temperature above or below body temperature, an electromagnetic emission and an oxidative environment, followed by administering back into patient |
| 05/02/2002 | US20020051763 Recombinant viral genome and nucleic acid sequence, carried by one or two plasmid supports, transcomplementing each other and allowing the host cell to produce defective infectious viruses |
| 05/02/2002 | US20020051761 Synthetic soil-extract materials and medicaments for herpes viruses based thereon |
| 05/02/2002 | US20020051758 Clear antiperspirants and deodorants made with siloxane-based polyamides |
| 05/02/2002 | US20020051753 Comprising a pressure-sensitive adhesive layer containing a drug on a cloth which prevents the dilution of drug by saliva |
| 05/02/2002 | US20020051749 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma |
| 05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
| 05/02/2002 | EP1201765A2 Cellular kinases involved in cytomegalovirus infection and their inhibition |
| 05/02/2002 | EP1201762A1 Process for producing lycopen |
| 05/02/2002 | EP1201678A1 Novel bicyclonucleoside analogues |
| 05/02/2002 | EP1201677A1 Novel macrolide compound jk |
| 05/02/2002 | EP1201676A2 PNA-DNA-PNA chimeric macromolecules |
| 05/02/2002 | EP1201670A2 Process for preparing 2-oxaisocephem derivatives |
| 05/02/2002 | EP1201668A1 Staurosporin derivatives |
| 05/02/2002 | EP1201663A1 Process for producing dibenzothiazepine derivatives |
| 05/02/2002 | EP1201660A1 Glucocorticoid receptor modulators |
| 05/02/2002 | EP1201655A2 Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| 05/02/2002 | EP1201649A1 Glucocorticoid receptor modulators |
| 05/02/2002 | EP1201639A2 Lipoxin compounds and their use in treating cell proliferative disorders |
| 05/02/2002 | EP1201268A2 Combinations of D4 dopamine receptor antagonists with acetylcholine esterase inhibitors |
| 05/02/2002 | EP1201248A2 Combination therapy of angiotensin converting enzyme inhibitor, side-effect reduced amount of aldosterone antagonist and diuretic for treatment of cardiovascular disease |
| 05/02/2002 | EP1201247A2 Treatment of tumor metastases and cancer |
| 05/02/2002 | EP1201246A2 Use of thrombopoietin as a medicament for the therapy and prevention of thrombocytopenia |
| 05/02/2002 | EP1201244A2 Anti-depressant, stress suppressor and mood improver |
| 05/02/2002 | EP1201243A1 Use of sulfadiazine and sulfadimidine for treating erectile dysfunction |
| 05/02/2002 | EP1201242A2 Use of mometasone furoate in an adjuvant therapy |
| 05/02/2002 | EP1201241A2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 05/02/2002 | EP1201240A2 Heterocyclic derivatives useful as pharmaceutical agents |